Chloroplasts (magenta color) in leaves expressing a green fluorescent protein. The DNA encoding for the protein was delivered by targeted nanomaterials without mechanical aid by applying a droplet of the nano-formulation to the leaf surface. (Israel Santana/UCR)
The future of vaccines may look more like eating a salad than getting a shot in the arm. UC Riverside scientists are studying whether they can turn edible plants like lettuce into mRNA vaccine factories.
Messenger RNA or mRNA technology, used in COVID-19 vaccines, works by teaching our cells to recognize and protect us against infectious diseases.
One of the challenges with this new technology is that it must be kept cold to maintain stability during transport and storage. If this new project is successful, plant-based mRNA vaccines — which can be eaten — could overcome this challenge with the ability to be stored at room temperature.
The project’s goals, made possible by a $500,000 grant from the National Science Foundation, are threefold: showing that DNA containing the mRNA vaccines can be successfully delivered into the part of plant cells where it will replicate, demonstrating the plants can produce enough mRNA to rival a traditional shot, and finally, determining the right dosage.
“Ideally, a single plant would produce enough mRNA to vaccinate a single person,” said Juan Pablo Giraldo, an associate professor in UCR’s Department of Botany and Plant Sciences who is leading the research, done in collaboration with scientists from UC San Diego and Carnegie Mellon University.
“We are testing this approach with spinach and lettuce and have long-term goals of people growing it in their own gardens,” Giraldo said. “Farmers could also eventually grow entire fields of it.”
Key to making this work are chloroplasts — small organs in plant cells that convert sunlight into energy the plant can use. “They’re tiny, solar-powered factories that produce sugar and other molecules which allow the plant to grow,” Giraldo said. “They’re also an untapped source for making desirable molecules.”
In the past, Giraldo has shown that it is possible for chloroplasts to express genes that aren’t naturally part of the plant. He and his colleagues did this by sending foreign genetic material into plant cells inside a protective casing. Determining the optimal properties of these casings for delivery into plant cells is a specialty of Giraldo’s laboratory.
For this project Giraldo teamed up with Nicole Steinmetz, a UC San Diego professor of nanoengineering, to utilize nanotechnologies engineered by her team that will deliver genetic material to the chloroplasts.
“Our idea is to repurpose naturally occurring nanoparticles, namely plant viruses, for gene delivery to plants,” Steinmetz said. “Some engineering goes into this to make the nanoparticles go to the chloroplasts and also to render them non-infectious toward the plants.”
For Giraldo, the chance to develop this idea with mRNA is the culmination of a dream. “One of the reasons I started working in nanotechnology was so I could apply it to plants and create new technology solutions. Not just for food, but for high-value products as well, like pharmaceuticals,” Giraldo said.
Giraldo is also co-leading a related project using nanomaterials to deliver nitrogen, a fertilizer, directly to chloroplasts, where plants need it most.
Nitrogen is limited in the environment, but plants need it to grow. Most farmers apply nitrogen to the soil. As a result, roughly half of it ends up in groundwater, contaminating waterways, causing algae blooms, and interacting with other organisms. It also produces nitrous oxide, another pollutant.
This alternative approach would get nitrogen into the chloroplasts through the leaves and control its release, a much more efficient mode of application that could help farmers and improve the environment.
Original Article: Grow and eat your own vaccines?
More from: University of California Riverside | Carnegie Mellon University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
mRNA factories
- German Factories Push Private Sector Into Surprise Slumpon July 24, 2024 at 12:41 am
Germany’s private sector unexpectedly contracted in July as country’s manufacturing malaise worsened — undermining hopes that growth will pick up in the second half of the year. S&P Global ...
- Modified Self-Amplifying RNA Provides Opportunities For New Vaccines And Treatmentson July 23, 2024 at 5:00 am
An infectious disease physician discusses new research results that could lead to innovations in vaccines and treatments.
- Egypt inaugurates BioGeneric Pharma factory to produce mRNA vaccines, biologicson July 22, 2024 at 5:00 pm
The factory consists for three main units for the ... South Africa and Tunisia will receive vaccine manufacturing support from the WHO’s mRNA technology transfer hub. The African countries ...
- Build A Factory Codes (July 2024)on July 14, 2024 at 10:45 pm
Follow our easy steps bellow in order to redeem Build a Factory codes: Of course, we also recommend bookmarking this page and checking back regularly. We’ll update our guide as soon as we spot ...
- 2024 Superconvergence Biorevolution Series: Journey To The mRNA Vaccine And Beyondon July 11, 2024 at 3:00 am
The development of mRNA vaccines like Moderna’s for COVID-19 was the result of over 150 years of scientific advancements in genetics, biotechnology and AI. mRNA technology has potential beyond ...
Go deeper with Google Headlines on:
mRNA factories
[google_news title=”” keyword=”mRNA factories” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Plant-based mRNA vaccines
- Moderna, Inc. (MRNA)on July 26, 2024 at 9:00 am
Moderna stock tumbled in late June after unveiling updated test results for its RSV vaccine. Is MRNA stock now a sell? Co-Founder and Co-Chairman of The Carlyle Group brings multi-industry ...
- RSV mRNA vaccine gets OK for older adultson July 23, 2024 at 12:29 pm
The US Food and Drug Administration has approved a messenger RNA-based vaccine against respiratory syncytial virus (RSV) for people aged 60 and older.
- Advancing mRNA Vaccine and Therapy Developmenton July 18, 2024 at 1:05 pm
To stay competitive, biopharmaceutical firms must adopt innovations like Next-Gen Gene Synthesis using Cell-Free Cloning to speed up therapeutic development.
- GSK buys mRNA-based Covid, flu vaccines from CureVac in restructured partnershipon July 3, 2024 at 4:47 am
GSK and CureVac have restructured an ongoing partnership that gives the British pharma giant control over the development of experimental mRNA-based Covid and flu vaccines.
- A Combination COVID and Flu Vaccine Is Coming Soonon July 2, 2024 at 4:59 pm
The chemical components that make up single-target vaccines can sometimes react with one another when combined, running the risk of making the individual drugs less effective. mRNA-based vaccines ...
Go deeper with Google Headlines on:
Plant-based mRNA vaccines
[google_news title=”” keyword=”plant-based mRNA vaccines” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]